{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:05:56Z","timestamp":1724285156761},"reference-count":139,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,21]]},"DOI":"10.7759\/cureus.67421","type":"journal-article","created":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T23:00:54Z","timestamp":1724281254000},"source":"Crossref","is-referenced-by-count":0,"title":["Genetic Insights Into Leukemia Susceptibility in the Arab Population: A Scoping Review"],"prefix":"10.7759","author":[{"given":"Abdulrahman","family":"Algarni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber DA","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al.. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016, 127:2391-405. 10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00355-z","article-title":"Leukaemia: a model metastatic disease","volume":"21","author":"Whiteley AE","year":"2021","unstructured":"Whiteley AE, Price TT, Cantelli G, Sipkins DA. Leukaemia: a model metastatic disease. Nat Rev Cancer. 2021, 21:461-75. 10.1038\/s41568-021-00355-z","journal-title":"Nat Rev Cancer"},{"key":"ref3","article-title":"Leukemia","author":"Chennamadhavuni A","year":"2024","unstructured":"Chennamadhavuni A, Lyengar V, Mukkamalla SKR, Shimanovsky A. Leukemia. StatPearls, Treasure Island, FL; 2024."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.904292","article-title":"Disease burden, risk factors, and trends of leukaemia: a global analysis","volume":"12","author":"Huang J","year":"2022","unstructured":"Huang J, Chan SC, Ngai CH, et al.. Disease burden, risk factors, and trends of leukaemia: a global analysis. Front Oncol. 2022, 12:904292. 10.3389\/fonc.2022.904292","journal-title":"Front Oncol"},{"key":"ref6","unstructured":"Cancer (IARC) TIA for R on. Global Cancer Observatory. (2024). Accessed: January 12, 2024: https:\/\/gco.iarc.fr\/."},{"key":"ref7","unstructured":"\u062c\u0627\u0645\u0639\u0629 \u0627\u0644\u062f\u0648\u0644 \u0627\u0644\u0639\u0631\u0628\u064a\u0629. (2024). Accessed. February 13, 2024: http:\/\/www.lasportal.org\/en\/Pages\/default.aspx."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco AC","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al.. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018, 169:467-73. 10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani M","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016, 5:210. 10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2022.9341","article-title":"Angiotensin-converting enzyme insertion\/deletion polymorphism (RS4646994) and susceptibility to acute lymphoblastic leukemia: a case-control study","volume":"10","author":"Abdulaziz ARA","year":"2022","unstructured":"Abdulaziz ARA, Ali EW. Angiotensin-converting enzyme insertion\/deletion polymorphism (RS4646994) and susceptibility to acute lymphoblastic leukemia: a case-control study. Open Access Maced J Med Sci. 2022, 10:997-1001. 10.3889\/oamjms.2022.9341","journal-title":"Open Access Maced J Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1179554917721710","article-title":"Cytogenetic profile and FLT3 gene mutations of childhood acute lymphoblastic leukemia","volume":"11","author":"Alkhayat N","year":"2017","unstructured":"Alkhayat N, Elborai Y, Al Sharif O, et al.. Cytogenetic profile and FLT3 gene mutations of childhood acute lymphoblastic leukemia. Clin Med Insights Oncol. 2017, 11:1179554917721710. 10.1177\/1179554917721710","journal-title":"Clin Med Insights Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4081\/itjm.2023.1644","article-title":"Association of methionine synthase reductase (MTRR A66G) polymorphism with susceptibility to acute lymphoblastic leukemia","volume":"17","author":"Edris MT","year":"2023","unstructured":"Edris MT, Merghani MM, Gafar SS, et al.. Association of methionine synthase reductase (MTRR A66G) polymorphism with susceptibility to acute lymphoblastic leukemia. Ital J Med. 2023, 17:10.4081\/itjm.2023.1644","journal-title":"Ital J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4172\/2329-6917.1000247","article-title":"CDKN2A and CDKN2B gene variants in acute lymphoblastic leukemia in Tunisian population","volume":"6","author":"Mahjoub T","year":"2018","unstructured":"Mahjoub T. CDKN2A and CDKN2B gene variants in acute lymphoblastic leukemia in Tunisian population. J Leuk. 2018, 6:10.4172\/2329-6917.1000247","journal-title":"J Leuk"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.21608\/rjab.2019.76807","article-title":"Association of C4125a polymorphisms of MDR-1 gene with childhood acute lymphoblastic leukaemia in Egyptian","volume":"5","author":"Talaat R","year":"2019","unstructured":"Talaat R, El-Kelliny M, El-Akhras B, Bakry R, Riad K, Guirgis A. Association of C4125a polymorphisms of MDR-1 gene with childhood acute lymphoblastic leukaemia in Egyptian. Res J Appl Biotechnol. 2019, 5:80-9. 10.21608\/rjab.2019.76807","journal-title":"Res J Appl Biotechnol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21608\/ejhm.2022.223321","article-title":"Impact of NQO1 c609t polymorphism on the outcome of childhood acute lymphoblastic leukemia from Zagazig University Hospital; Egypt","volume":"87","author":"Eissa M","year":"2022","unstructured":"Eissa M, Zidan AA, Hossein OA, Omran AA. Impact of NQO1 c609t polymorphism on the outcome of childhood acute lymphoblastic leukemia from Zagazig University Hospital; Egypt. Egypt J Hosp Med. 2022, 87:1293-6. 10.21608\/ejhm.2022.223321","journal-title":"Egypt J Hosp Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2022.102139","article-title":"Evaluation of the relationships between HLA-G 14 bp polymorphism and two acute leukemia in a Saudi population","volume":"34","author":"Al-Tamimi J","year":"2022","unstructured":"Al-Tamimi J, Al Omar SY, Al-Khulaifi F, Aljuaimlani A-, Alharbi SA, Al-jurayyan A, Mansour L. Evaluation of the relationships between HLA-G 14 bp polymorphism and two acute leukemia in a Saudi population. J King Saud Univ - Sci. 2022, 34:102139. 10.1016\/j.jksus.2022.102139","journal-title":"J King Saud Univ - Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2018.19.1.199","article-title":"Genetic polymorphism of thiopurine S-methyltransferase in children with acute lymphoblastic leukemia in Jordan","volume":"19","author":"Alsous M","year":"2018","unstructured":"Alsous M, Yousef AM, Abdel Jalil M, et al.. Genetic polymorphism of thiopurine S-methyltransferase in children with acute lymphoblastic leukemia in Jordan. Asian Pac J Cancer Prev. 2018, 19:199-205. 10.22034\/APJCP.2018.19.1.199","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1004170","article-title":"Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and susceptibility to acute lymphoblastic leukemia in a cohort of Egyptian children","volume":"56","author":"Mosaad YM","year":"2015","unstructured":"Mosaad YM, Abousamra NK, Elashery R, Fawzy IM, Eldein OA, Sherief DM, El Azab HM. Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and susceptibility to acute lymphoblastic leukemia in a cohort of Egyptian children. Leuk Lymphoma. 2015, 56:2699-705. 10.3109\/10428194.2015.1004170","journal-title":"Leuk Lymphoma"},{"key":"ref19","article-title":"Role of CTLA4-49A polymorphism in the pathogenesis of acute leukemia","volume":"4","author":"Hawass M","year":"2020","unstructured":"Hawass M, Afifi E, Hazaa I, Ebid G. Role of CTLA4-49A polymorphism in the pathogenesis of acute leukemia. Sci J Al-Azhar Medical Faculty, Girls. 2020, 4:192.","journal-title":"Sci J Al-Azhar Medical Faculty, Girls"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2021.101237","article-title":"The role of miRNA-196a2 genotypes in the susceptibility of acute lymphoblastic leukemia in Egyptian children","volume":"24","author":"Abd El Hassib DM","year":"2021","unstructured":"Abd El Hassib DM, Abdulhafeez NA, Atef OM, Ameen SG. The role of miRNA-196a2 genotypes in the susceptibility of acute lymphoblastic leukemia in Egyptian children. Gene Rep. 2021, 24:101237. 10.1016\/j.genrep.2021.101237","journal-title":"Gene Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317697573","article-title":"Association of ARID5B gene variants with acute lymphoblastic leukemia in Yemeni children","volume":"39","author":"Al-Absi B","year":"2017","unstructured":"Al-Absi B, Noor SM, Saif-Ali R, Salem SD, Ahmed RH, Razif MF, Muniandy S. Association of ARID5B gene variants with acute lymphoblastic leukemia in Yemeni children. Tumour Biol. 2017, 39:1010428317697573. 10.1177\/1010428317697573","journal-title":"Tumour Biol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2019.1649333","article-title":"ARID5B rs10821936 and rs10994982 gene polymorphisms and acute lymphoblastic leukemia: relation to disease susceptibility and outcome","volume":"36","author":"Mosaad YM","year":"2019","unstructured":"Mosaad YM, Khashaba M, Darwish A, et al.. ARID5B rs10821936 and rs10994982 gene polymorphisms and acute lymphoblastic leukemia: relation to disease susceptibility and outcome. Pediatr Hematol Oncol. 2019, 36:365-75. 10.1080\/08880018.2019.1649333","journal-title":"Pediatr Hematol Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2023.24.1.337","article-title":"Association of two ARID5B gene variant single nucleotide polymorphisms with acute lymphoblastic leukemia in the Egyptian population","volume":"24","author":"Gamaleldin MA","year":"2023","unstructured":"Gamaleldin MA, Imbaby SA. Association of two ARID5B gene variant single nucleotide polymorphisms with acute lymphoblastic leukemia in the Egyptian population. Asian Pac J Cancer Prev. 2023, 24:337-43. 10.31557\/APJCP.2023.24.1.337","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref24","article-title":"Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer","volume":"18","author":"Bedewy AM","year":"2013","unstructured":"Bedewy AM, Mostafa MH, Saad AA, El-Maghraby SM, Bedewy MM, Hilal AM, Kandil LS. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer. J BUON. 2013, 18:227-38.","journal-title":"J BUON"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.32007\/med.1936\/jfacmedbagdad.v56i4.11","article-title":"Association between leukemia and exon 2 CD19 gene variants in a sample of Iraqi patients","volume":"56","author":"Ahmed NS","year":"2014","unstructured":"Ahmed NS, Al-Hadeithi ZS, Nada SM, Hadi YA. Association between leukemia and exon 2 CD19 gene variants in a sample of Iraqi patients. J Faculty Med Baghdad. 2014, 56:390-4.","journal-title":"J Faculty Med Baghdad"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2017.0084","article-title":"Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 gene polymorphisms to acute lymphoblastic leukemia in a Yemeni population","volume":"21","author":"Al-Absi B","year":"2017","unstructured":"Al-Absi B, Razif MF, Noor SM, et al.. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 gene polymorphisms to acute lymphoblastic leukemia in a Yemeni population. Genet Test Mol Biomarkers. 2017, 21:592-9. 10.1089\/gtmb.2017.0084","journal-title":"Genet Test Mol Biomarkers"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.809527","article-title":"Polymorphism of CYP1A1 gene and susceptibility to childhood acute lymphoblastic leukemia in Egypt","volume":"55","author":"Agha A","year":"2014","unstructured":"Agha A, Shabaan H, Abdel-Gawad E, El-Ghannam D. Polymorphism of CYP1A1 gene and susceptibility to childhood acute lymphoblastic leukemia in Egypt. Leuk Lymphoma. 2014, 55:618-23. 10.3109\/10428194.2013.809527","journal-title":"Leuk Lymphoma"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0265-4","article-title":"Factor V Leiden 1691G\/A and prothrombin gene 20210G\/A polymorphisms as prothrombotic markers in adult Egyptian acute leukemia patients","volume":"31","author":"El Sissy AH","year":"2014","unstructured":"El Sissy AH, El Sissy MH, Elmoamly S. Factor V Leiden 1691G\/A and prothrombin gene 20210G\/A polymorphisms as prothrombotic markers in adult Egyptian acute leukemia patients. Med Oncol. 2014, 31:265. 10.1007\/s12032-014-0265-4","journal-title":"Med Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-022-00549-3","article-title":"Genetic variation in FOXP3 and ROR-\u03b3 genes in pediatric acute lymphocytic leukemia (ALL) patients: correlation with associated cytokines","volume":"13","author":"El-Maadawy EA","year":"2022","unstructured":"El-Maadawy EA, Bakry RM, Moussa MM, El-Naby SH, Talaat RM. Genetic variation in FOXP3 and ROR-\u03b3 genes in pediatric acute lymphocytic leukemia (ALL) patients: correlation with associated cytokines. Discov Oncol. 2022, 13:86. 10.1007\/s12672-022-00549-3","journal-title":"Discov Oncol"},{"key":"ref30","article-title":"FOXP3 polymorphism and susceptibility to pediatric acute lymphocytic leukemia (ALL): a preliminary data","volume":"53","author":"El-maadawy EA","year":"2020","unstructured":"El-maadawy EA, Bakry RM, Moussa MM, El-Naby SH, Talaat RM. FOXP3 polymorphism and susceptibility to pediatric acute lymphocytic leukemia (ALL): a preliminary data. IJSBAR. 2020, 53:159-70.","journal-title":"IJSBAR"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1204656","article-title":"GATA3 rs3824662 gene polymorphism as possible risk factor in a cohort of Egyptian patients with pediatric acute lymphoblastic leukemia and its prognostic impact","volume":"58","author":"Mosaad YM","year":"2017","unstructured":"Mosaad YM, Elashery R, Darwish A, et al.. GATA3 rs3824662 gene polymorphism as possible risk factor in a cohort of Egyptian patients with pediatric acute lymphoblastic leukemia and its prognostic impact. Leuk Lymphoma. 2017, 58:689-98. 10.1080\/10428194.2016.1204656","journal-title":"Leuk Lymphoma"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S356302","article-title":"Increased risk of acute lymphoblastic leukemia in adult patients with GSTM1 null genetic polymorphism","volume":"15","author":"Abdalhabib EK","year":"2022","unstructured":"Abdalhabib EK, Alzahrani B, Alanazi F, et al.. Increased risk of acute lymphoblastic leukemia in adult patients with GSTM1 null genetic polymorphism. Pharmgenomics Pers Med. 2022, 15:227-34. 10.2147\/PGPM.S356302","journal-title":"Pharmgenomics Pers Med"},{"key":"ref33","article-title":"GSTM1 genotype as a risk modifier of MDR1 C3435T-induced risk susceptibility to pediatric acute lymphoblastic leukemia","volume":"7","author":"Ebid GT","year":"2011","unstructured":"Ebid GT, KASSEM SH. GSTM1 genotype as a risk modifier of MDR1 C3435T-induced risk susceptibility to pediatric acute lymphoblastic leukemia. J Egypt Soc Haematol Res. 2011, 7:65-72.","journal-title":"J Egypt Soc Haematol Res"},{"key":"ref34","article-title":"Genetic polymorphisms of GSTM1 and GSTT1 genes and susceptibility to acute lymphoblastic leukemia in the Yemeni population","volume":"43","author":"Saleh R","year":"2022","unstructured":"Saleh R, Musa HH, Hamid GA, Hamid MMA. Genetic polymorphisms of GSTM1 and GSTT1 genes and susceptibility to acute lymphoblastic leukemia in the Yemeni population. Asian Hematol Res J. 2022, 43:51.","journal-title":"Asian Hematol Res J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.36349\/easms.2019.v02i05.017","article-title":"Frequencies of GSTP1 (Ile105Val) polymorphism and its association with acute lymphoblastic leukemia in Yemeni patients","volume":"2","author":"Saleh R","year":"2019","unstructured":"Saleh R, Musa HH, Hamid GA, Hamid MMA. Frequencies of GSTP1 (Ile105Val) polymorphism and its association with acute lymphoblastic leukemia in Yemeni patients. East African Scholars J Med Sci. 2019, 2:10.36349\/easms.2019.v02i05.017","journal-title":"East African Scholars J Med Sci"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-020-00128-7","article-title":"The role of glutathione S-transferase omega gene polymorphisms in childhood acute lymphoblastic leukemia: a case-control study","volume":"22","author":"Yassa ME","year":"2021","unstructured":"Yassa ME, Arnaout HH, Botros SK, Obaid EN, Mahmoud WM, Morgan DS. The role of glutathione S-transferase omega gene polymorphisms in childhood acute lymphoblastic leukemia: a case-control study. Egypt J Med Hum Genet. 2021, 22:17. 10.1186\/s43042-020-00128-7","journal-title":"Egypt J Med Hum Genet"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2017.1289324","article-title":"HFE gene mutation and iron overload in Egyptian pediatric acute lymphoblastic leukemia survivors: a single-center study","volume":"22","author":"El-Rashedi FH","year":"2017","unstructured":"El-Rashedi FH, El-Hawy MA, El-Hefnawy SM, Mohammed MM. HFE gene mutation and iron overload in Egyptian pediatric acute lymphoblastic leukemia survivors: a single-center study. Hematology. 2017, 22:398-404. 10.1080\/10245332.2017.1289324","journal-title":"Hematology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.24126\/jobrc.2014.8.4.373","article-title":"HLA polymorphism in a sample of Iraqi acute lymphoid leukemia patients","volume":"8","author":"Ali EN","year":"2014","unstructured":"Ali EN, Ad\u2019hiah AH, Al-Demardak AS. HLA polymorphism in a sample of Iraqi acute lymphoid leukemia patients. JoBRC. 2014, 8:22-6. 10.24126\/jobrc.2014.8.4.373","journal-title":"JoBRC"},{"key":"ref39","article-title":"HLA-DQA1 and -DQB1: alleles as risk factors for acute lymphoblastic leukemia","volume":"14","author":"Abdul-Rahman MT","year":"2022","unstructured":"Abdul-Rahman MT, Al-Ammar NS, Kreyenberg H. HLA-DQA1 and -DQB1: alleles as risk factors for acute lymphoblastic leukemia. Iranian J War Public Health. 2022, 14:189-95.","journal-title":"Iranian J War Public Health"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-019-0900-1","article-title":"IKZF1 genetic variants rs4132601 and rs11978267 and acute lymphoblastic leukemia risk in Tunisian children: a case-control study","volume":"20","author":"Mahjoub S","year":"2019","unstructured":"Mahjoub S, Chayeb V, Zitouni H, Ghali RM, Regaieg H, Almawi WY, Mahjoub T. IKZF1 genetic variants rs4132601 and rs11978267 and acute lymphoblastic leukemia risk in Tunisian children: a case-control study. BMC Med Genet. 2019, 20:159. 10.1186\/s12881-019-0900-1","journal-title":"BMC Med Genet"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S377356","article-title":"IL-10 RS1800896 polymorphism: a risk factor for adult acute lymphoblastic leukemia","volume":"15","author":"Abdalhabib EK","year":"2022","unstructured":"Abdalhabib EK, Alzahrani B, Saboor M, et al.. IL-10 RS1800896 polymorphism: a risk factor for adult acute lymphoblastic leukemia. Pharmgenomics Pers Med. 2022, 15:809-15. 10.2147\/PGPM.S377356","journal-title":"Pharmgenomics Pers Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.910659","article-title":"Influence of interleukin-15 polymorphism on the survival of adult patients with acute lymphoblastic leukemia in Egypt","volume":"56","author":"Aly RM","year":"2015","unstructured":"Aly RM, Taalab MM, Ghazy HF. Influence of interleukin-15 polymorphism on the survival of adult patients with acute lymphoblastic leukemia in Egypt. Leuk Lymphoma. 2015, 56:151-6. 10.3109\/10428194.2014.910659","journal-title":"Leuk Lymphoma"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2022.102493","article-title":"Assessment of the relationships between IL-17A polymorphisms and the risk to acute lymphoblastic leukemia in Saudi population","volume":"35","author":"Al-Juaimlani A","year":"2023","unstructured":"Al-Juaimlani A, Al-Omar S, Al-Jurayyan A, Al-Khulaifi F, Al-Tamimi J, Mansour L. Assessment of the relationships between IL-17A polymorphisms and the risk to acute lymphoblastic leukemia in Saudi population. J King Saud Univ - Sci. 2023, 35:102493. 10.1016\/j.jksus.2022.102493","journal-title":"J King Saud Univ - Sci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2017.05.002","article-title":"Association between the killer cell immunoglobulin-like receptor a haplotype and childhood acute lymphoblastic leukemia","volume":"78","author":"Osman AE","year":"2017","unstructured":"Osman AE, AlJuryyan A, Alharthi H, Almoshary M. Association between the killer cell immunoglobulin-like receptor a haplotype and childhood acute lymphoblastic leukemia. Hum Immunol. 2017, 78:510-4. 10.1016\/j.humimm.2017.05.002","journal-title":"Hum Immunol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.36295\/ASRO.2019.221017","article-title":"Molecular effect MDR1(C3435T) gene polymorphism on leukemia patients in Babylon province, Iraq","volume":"22","author":"Mekkey AM","year":"2019","unstructured":"Mekkey AM, Abed AS, Jasim ZM, Jawad NN. Molecular effect MDR1(C3435T) gene polymorphism on leukemia patients in Babylon province, Iraq. ATMPH. 2019, 22:115-9. 10.36295\/ASRO.2019.221017","journal-title":"ATMPH"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s00580-013-1859-5","article-title":"The role of MDR1 (C3435T) gene polymorphism in Egyptian acute lymphoblastic leukemia","volume":"24","author":"El-hoseiny SM","year":"2015","unstructured":"El-hoseiny SM, Elhadidy KE-S, Ahmed SM, Khallaf AM. The role of MDR1 (C3435T) gene polymorphism in Egyptian acute lymphoblastic leukemia. Comp Clin Pathol. 2015, 24:79-88. 10.1007\/s00580-013-1859-5","journal-title":"Comp Clin Pathol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2018.19.9.2535","article-title":"Association of C3435T, C1236T and C4125a polymorphisms of the MDR-1 gene in Egyptian children with acute lymphoblastic leukaemia","volume":"19","author":"Talaat RM","year":"2018","unstructured":"Talaat RM, Y K El-Kelliny M, El-Akhras BA, Bakry RM, Riad KF, Guirgis AA. Association of C3435T, C1236T and C4125a polymorphisms of the MDR-1 gene in Egyptian children with acute lymphoblastic leukaemia. Asian Pac J Cancer Prev. 2018, 19:2535-43. 10.22034\/APJCP.2018.19.9.2535","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref48","article-title":"Polymorphisms in the methylenetetrahydrofolate reductase gene and its relation to adult acute lymphoblastic leukemia","volume":"11","author":"El-Masry S","year":"2015","unstructured":"El-Masry S, Elnahass YH, Metawea BM. Polymorphisms in the methylenetetrahydrofolate reductase gene and its relation to adult acute lymphoblastic leukemia. Egypt J Exp Biol. 2015, 11:171-6.","journal-title":"Egypt J Exp Biol"},{"key":"ref49","article-title":"Synergistic effect of methyltetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphism as risk modifiers of pediatric acute lymphoblastic leukemia","volume":"19","author":"Kamel AM","year":"2007","unstructured":"Kamel AM, Moussa HS, Ebid GT, Bu RR, Bhatia KG. Synergistic effect of methyltetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphism as risk modifiers of pediatric acute lymphoblastic leukemia. J Egypt Natl Canc Inst. 2007, 19:96-105.","journal-title":"J Egypt Natl Canc Inst"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-3320-7","article-title":"N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia","volume":"36","author":"Kamel AM","year":"2015","unstructured":"Kamel AM, Ebid GT, Moussa HS. N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia. Tumour Biol. 2015, 36:6341-8. 10.1007\/s13277-015-3320-7","journal-title":"Tumour Biol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-012-2174-y","article-title":"Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population","volume":"40","author":"Ouerhani S","year":"2013","unstructured":"Ouerhani S, Cherif N, Bahri I, Safra I, Menif S, Abbes S. Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population. Mol Biol Rep. 2013, 40:1307-14. 10.1007\/s11033-012-2174-y","journal-title":"Mol Biol Rep"},{"key":"ref52","article-title":"The predisposing role of NAD (P) H: quinine oxidoreductase gene polymorphisms in the development of pediatric acute lymphoblastic leukemia","volume":"45","author":"Abdelaziz H","year":"2005","unstructured":"Abdelaziz H, Alqatary A. The predisposing role of NAD (P) H: quinine oxidoreductase gene polymorphisms in the development of pediatric acute lymphoblastic leukemia. J Egypt Soc Haematol Res. 2005, 45:","journal-title":"J Egypt Soc Haematol Res"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.21037\/tp-22-512","article-title":"Comprehensive genetic analyses of childhood acute leukemia in Iraq using next-generation sequencing","volume":"12","author":"Al-Kzayer LF","year":"2023","unstructured":"Al-Kzayer LF, Saeed RM, Ghali HH, et al.. Comprehensive genetic analyses of childhood acute leukemia in Iraq using next-generation sequencing. Transl Pediatr. 2023, 12:827-44. 10.21037\/tp-22-512","journal-title":"Transl Pediatr"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/genes13071237","article-title":"Association of TNF-\u03b1 rs1800629 with adult acute B-cell lymphoblastic leukemia","volume":"13","author":"Abdalhabib EK","year":"2022","unstructured":"Abdalhabib EK, Algarni A, Saboor M, et al.. Association of TNF-\u03b1 rs1800629 with adult acute B-cell lymphoblastic leukemia. Genes (Basel). 2022, 13:10.3390\/genes13071237","journal-title":"Genes (Basel)"},{"key":"ref55","article-title":"MDM2 SNP309 and p53 codon 72 genetic polymorphisms and risk of AML: an Egyptian study","volume":"44","author":"El-Danasouri NM","year":"2014","unstructured":"El-Danasouri NM, Ragab SH, Rasheed MA, Ali El Saadany Z, Abd El-Fattah SN. MDM2 SNP309 and p53 codon 72 genetic polymorphisms and risk of AML: an Egyptian study. Ann Clin Lab Sci. 2014, 44:449-54.","journal-title":"Ann Clin Lab Sci"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.4103\/ejh.ejh_81_22","article-title":"DNMT3A-448A>G nucleotide polymorphism and susceptibility to acute myeloid leukemia in a cohort of Egyptian patients","volume":"47","author":"Elnoshokaty E","year":"2022","unstructured":"Elnoshokaty E, Ebid G, Fahmy M, Shikhon T, Gawdat R. DNMT3A-448A>G nucleotide polymorphism and susceptibility to acute myeloid leukemia in a cohort of Egyptian patients. Egypt J Haematol. 2022, 47:294. 10.4103\/ejh.ejh_81_22","journal-title":"Egypt J Haematol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.21786\/bbrc\/12.3\/4","article-title":"Genetic polymorphism studies in MTHFR gene with acute myeloid leukemia in the Saudi population","volume":"12","author":"Farasani A","year":"2019","unstructured":"Farasani A. Genetic polymorphism studies in MTHFR gene with acute myeloid leukemia in the Saudi population. Biosci Biotechnol Res Commun. 2019, 12:10.21786\/bbrc\/12.3\/4","journal-title":"Biosci Biotechnol Res Commun"},{"key":"ref58","article-title":"Effect of MDR1 gene expression related with C1236T polymorphism in Iraqi acute myeloid leukemia patients","volume":"13","author":"Alyaqubi AHMA F 1 KJ","year":"2014","unstructured":"Alyaqubi AHMA F 1 KJ. Effect of MDR1 gene expression related with C1236T polymorphism in Iraqi acute myeloid leukemia patients. Iraqi J Biotechnol. 2014, 13:","journal-title":"Iraqi J Biotechnol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2019.06.001","article-title":"MDR1 gene polymorphisms and acute myeloid leukemia AML susceptibility in a Moroccan adult population: a case-control study and meta-analysis","volume":"68","author":"Kaltoum AB","year":"2020","unstructured":"Kaltoum AB, Sellama N, Hind D, Yaya K, Mouna L, Asma Q. MDR1 gene polymorphisms and acute myeloid leukemia AML susceptibility in a Moroccan adult population: a case-control study and meta-analysis. Curr Res Transl Med. 2020, 68:29-35. 10.1016\/j.retram.2019.06.001","journal-title":"Curr Res Transl Med"},{"key":"ref60","article-title":"High frequency of nucleophosmin mutations in thirty two Iraqi adult patients with acute myeloid leukemia","volume":"2","author":"Dhahir EK","year":"2012","unstructured":"Dhahir EK, Dhahi MAR. High frequency of nucleophosmin mutations in thirty two Iraqi adult patients with acute myeloid leukemia. Int J Appl Sci Technol. 2012, 2:","journal-title":"Int J Appl Sci Technol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2018.12.011","article-title":"Genetic variants of glutathione S-transferase and the risk of acute myeloid leukemia in a Saudi population","volume":"26","author":"Farasani A","year":"2019","unstructured":"Farasani A. Genetic variants of glutathione S-transferase and the risk of acute myeloid leukemia in a Saudi population. Saudi J Biol Sci. 2019, 26:1525-30. 10.1016\/j.sjbs.2018.12.011","journal-title":"Saudi J Biol Sci"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2019.306","article-title":"Interleukin-17 gene polymorphism is protective against the susceptibility to adult acute myeloid leukaemia in Egypt: a case-control study","volume":"7","author":"Elsissy M","year":"2019","unstructured":"Elsissy M, Abdelhafez A, Elmasry M, Salah D. Interleukin-17 gene polymorphism is protective against the susceptibility to adult acute myeloid leukaemia in Egypt: a case-control study. Open Access Maced J Med Sci. 2019, 7:1425-9. 10.3889\/oamjms.2019.306","journal-title":"Open Access Maced J Med Sci"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2020_6235","article-title":"A case-control study in NAT2 gene polymorphism studies in patients diagnosed with acute myeloid leukemia","volume":"70","author":"Farasani A","year":"2023","unstructured":"Farasani A. A case-control study in NAT2 gene polymorphism studies in patients diagnosed with acute myeloid leukemia. Acta Biochim Pol. 2023, 70:503-7. 10.18388\/abp.2020_6235","journal-title":"Acta Biochim Pol"},{"key":"ref64","article-title":"The association of TNF-\u03b1 -308 G\/A gene with acute myeloid leukemia for Iraqi patients","volume":"22","author":"Dhabaan AAN","year":"2022","unstructured":"Dhabaan AAN, Hassan HNA. The association of TNF-\u03b1 -308 G\/A gene with acute myeloid leukemia for Iraqi patients. HIV Nursing. 2022, 22:156-8.","journal-title":"HIV Nursing"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2012.0278","article-title":"The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia","volume":"17","author":"Sorour A","year":"2013","unstructured":"Sorour A, Ayad MW, Kassem H. The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia. Genet Test Mol Biomarkers. 2013, 17:195-201. 10.1089\/gtmb.2012.0278","journal-title":"Genet Test Mol Biomarkers"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.4103\/ejh.ejh_91_22","article-title":"Polymorphisms of the DNA repair genes (APE1, XPD, and RAD51) and the risk of developing cytogenetic abnormalities in a cohort of Egyptian patients with newly diagnosed AML","volume":"48","author":"El-Noshokaty EH","year":"2023","unstructured":"El-Noshokaty EH, Ebid GT, Ayoub MA, Gawdat RM. Polymorphisms of the DNA repair genes (APE1, XPD, and RAD51) and the risk of developing cytogenetic abnormalities in a cohort of Egyptian patients with newly diagnosed AML. Egypt J Haematol. 2023, 48:112. 10.4103\/ejh.ejh_91_22","journal-title":"Egypt J Haematol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.21123\/bsj.2023.8294","article-title":"The role of the APE1 Asp148Glu polymorphism on the risk of acute myeloid leukemia in Iraqi patients","author":"Jasiem T","year":"2023","unstructured":"Jasiem T, Al-Husseini R. The role of the APE1 Asp148Glu polymorphism on the risk of acute myeloid leukemia in Iraqi patients. Baghdad Sci J. 2023, 10.21123\/bsj.2023.8294","journal-title":"Baghdad Sci J"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1007\/s12308-022-00508-5","article-title":"The risk and prognostic influence of caspase 9 promotor polymorphisms in Egyptian patients with acute myeloid leukemia","volume":"15","author":"Makhlouf MM","year":"2022","unstructured":"Makhlouf MM, Ayoub MA, Mourad DF. The risk and prognostic influence of caspase 9 promotor polymorphisms in Egyptian patients with acute myeloid leukemia. J Hematopathol. 2022, 15:131-40. 10.1007\/s12308-022-00508-5","journal-title":"J Hematopathol"},{"key":"ref69","article-title":"The impact of genetic polymorphisms of cytochrome P450 (CYP1A1&2D6) gene in the incidence of acute myeloid leukaemia","volume":"14","author":"Diab NA","year":"2020","unstructured":"Diab NA, Elderdery AY, Mills J, et al.. The impact of genetic polymorphisms of cytochrome P450 (CYP1A1&2D6) gene in the incidence of acute myeloid leukaemia. Pakistani J Med Health Sci. 2020, 14:1221-6.","journal-title":"Pakistani J Med Health Sci"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-021-00145-0","article-title":"Impact of cytochromes P450 3A4 and 2B6 gene polymorphisms on predisposition and prognosis of acute myeloid leukemia: an Egyptian case-control study","volume":"22","author":"Botros SKA","year":"2021","unstructured":"Botros SKA, El Gharbawi N, Shahin G, Al Lithy H, El Sherbiny M. Impact of cytochromes P450 3A4 and 2B6 gene polymorphisms on predisposition and prognosis of acute myeloid leukemia: an Egyptian case-control study. Egypt J Med Hum Genet. 2021, 22:38. 10.1186\/s43042-021-00145-0","journal-title":"Egypt J Med Hum Genet"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2013.10.002","article-title":"Frequency and prognostic significant of CYP3A4-A-290G polymorphism in acute myeloid leukemia","volume":"5","author":"Ali GT","year":"2014","unstructured":"Ali GT, Al-Azhary NM, Mokhtar DA. Frequency and prognostic significant of CYP3A4-A-290G polymorphism in acute myeloid leukemia. J Adv Res. 2014, 5:657-61. 10.1016\/j.jare.2013.10.002","journal-title":"J Adv Res"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2017.18.3.747","article-title":"Association of CYP3A5*3 and Cyp1a1*2c polymorphism with development of acute myeloid leukemia in Egyptian patients","volume":"18","author":"Abd El Wahab N","year":"2017","unstructured":"Abd El Wahab N, Shafik NF, Shafik RE, Taha ShA, Shafik HE, Darwish AD. Association of CYP3A5*3 and Cyp1a1*2c polymorphism with development of acute myeloid leukemia in Egyptian patients. Asian Pac J Cancer Prev. 2017, 18:747-52. 10.22034\/APJCP.2017.18.3.747","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref73","article-title":"DNMT3A gene polymorphismin Iraqi acute myeloid leukemia patients and its relation to prognostic factors and response to therapy","volume":"4301","author":"Fadhil AS","year":"2021","unstructured":"Fadhil AS, Alwash DMM, Ahmed DAA. DNMT3A gene polymorphismin Iraqi acute myeloid leukemia patients and its relation to prognostic factors and response to therapy. Ann Roman Soc Cell Biol. 2021, 4301:9.","journal-title":"Ann Roman Soc Cell Biol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2020.08.001","article-title":"The influence of DNMT3A and DNMT3B gene polymorphisms on acute myeloid leukemia risk in a Moroccan population","volume":"68","author":"Ait Boujmia OK","year":"2020","unstructured":"Ait Boujmia OK, Nadifi S, Dehbi H, Lamchahab M, Quessar A. The influence of DNMT3A and DNMT3B gene polymorphisms on acute myeloid leukemia risk in a Moroccan population. Curr Res Transl Med. 2020, 68:191-5. 10.1016\/j.retram.2020.08.001","journal-title":"Curr Res Transl Med"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.22317\/jcms.v9i1.1308","article-title":"The impact of the ERCC2 Lys751gln polymorphism on the risk of acute myeloid leukemia in an Iraqi patients","volume":"9","author":"Jasiem TM","year":"2023","unstructured":"Jasiem TM, Abdul-Hussain Al-Hussaini RM. The impact of the ERCC2 Lys751gln polymorphism on the risk of acute myeloid leukemia in an Iraqi patients. J Contemp Med Sci. 2023, 9:10.22317\/jcms.v9i1.1308","journal-title":"J Contemp Med Sci"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.31557\/apjcb.2019.4.1.7-10","article-title":"GSTM1 and GSTT1 polymorphisms and susceptibility to acute myeloid leukemia: a case-control study of the Sudanese population","volume":"4","author":"Babekir EA","year":"2019","unstructured":"Babekir EA, Abdelateif NM, Adelrahim SO, Hassan R, Ibrahim IK. GSTM1 and GSTT1 polymorphisms and susceptibility to acute myeloid leukemia: a case-control study of the Sudanese population. Asian Pac J Cancer Biol. 2019, 4:7-10. 10.31557\/apjcb.2019.4.1.7-10","journal-title":"Asian Pac J Cancer Biol"},{"key":"ref77","article-title":"Possible role of anti-inflammatory cytokine gene polymorphism in AML susceptibility, Egypt","volume":"15","author":"Rashed R","year":"2016","unstructured":"Rashed R, Ezzat R, Fawzy N, Ezzat H. Possible role of anti-inflammatory cytokine gene polymorphism in AML susceptibility, Egypt. 5th World Hematologists Congress. 2016, 15:17.","journal-title":"5th World Hematologists Congress"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.mgene.2020.100773","article-title":"IL-17 A and IL-17 F single nucleotide polymorphisms and acute myeloid leukemia susceptibility and response to induction therapy in Egypt","volume":"26","author":"Zayed RA","year":"2020","unstructured":"Zayed RA, El-Saadany Z, Raslan HN, et al.. IL-17 A and IL-17 F single nucleotide polymorphisms and acute myeloid leukemia susceptibility and response to induction therapy in Egypt. Meta Gene. 2020, 26:100773. 10.1016\/j.mgene.2020.100773","journal-title":"Meta Gene"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-022-00253-5","article-title":"Interleukin-4 gene intron 3 VNTR polymorphism in adult acute myeloid leukemia","volume":"23","author":"Safwat NA","year":"2022","unstructured":"Safwat NA, Najjar MRE, Saeed AM, Mohamed HS. Interleukin-4 gene intron 3 VNTR polymorphism in adult acute myeloid leukemia. Egypt J Med Hum Genet. 2022, 23:43. 10.1186\/s43042-022-00253-5","journal-title":"Egypt J Med Hum Genet"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.21608\/jbaar.2018.154462","article-title":"IL\u201117F and IL- 23 gene polymorphism in patients with acute myeloid leukemia, an Egyptian study","volume":"4","author":"Nasr A","year":"2018","unstructured":"Nasr A, El Azizy H, El Husseiny N, Youssef S. IL\u201117F and IL- 23 gene polymorphism in patients with acute myeloid leukemia, an Egyptian study. J Biosci Appl Res. 2018, 4:469-77. 10.21608\/jbaar.2018.154462","journal-title":"J Biosci Appl Res"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2020_5945","article-title":"Screening of V617F mutation in JAK2 gene with acute myeloid leukemia in the Saudi population","volume":"69","author":"Farasani A","year":"2022","unstructured":"Farasani A. Screening of V617F mutation in JAK2 gene with acute myeloid leukemia in the Saudi population. Acta Biochim Pol. 2022, 69:211-4. 10.18388\/abp.2020_5945","journal-title":"Acta Biochim Pol"},{"key":"ref82","article-title":"MDM2, p53 and p21 gene polymorphisms in acute myeloid leukemia","volume":"63","author":"ElGamal BM","year":"2005","unstructured":"ElGamal BM. MDM2, p53 and p21 gene polymorphisms in acute myeloid leukemia. J Egypt Soc Haematol Res. 2005, 63:","journal-title":"J Egypt Soc Haematol Res"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2012.13.9.4315","article-title":"MDM2 T309G has a synergistic effect with P21 ser31arg single nucleotide polymorphisms on the risk of acute myeloid leukemia","volume":"13","author":"Ebid GT","year":"2012","unstructured":"Ebid GT, Sedhom IA, El-Gammal MM, Moneer MM. MDM2 T309G has a synergistic effect with P21 ser31arg single nucleotide polymorphisms on the risk of acute myeloid leukemia. Asian Pac J Cancer Prev. 2012, 13:4315-20. 10.7314\/apjcp.2012.13.9.4315","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2022.102439","article-title":"Experimental study of A66G-single nucleotide polymorphism in the MTRR gene and acute myeloid leukemia","volume":"35","author":"Farasani A","year":"2023","unstructured":"Farasani A. Experimental study of A66G-single nucleotide polymorphism in the MTRR gene and acute myeloid leukemia. J King Saud Univ - Sci. 2023, 35:102439. 10.1016\/j.jksus.2022.102439","journal-title":"J King Saud Univ - Sci"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.4103\/ejh.ejh_20_19","article-title":"Study of N-acetyl transferase 2 single-gene polymorphism (rs1799931) in patients with acute myeloid leukemia","volume":"44","author":"AbdelGhafar MT","year":"2019","unstructured":"AbdelGhafar MT, Allam AA, Darwish S, Al-Ashmawy GM, Eshra KA, Ibrahim RR. Study of N-acetyl transferase 2 single-gene polymorphism (rs1799931) in patients with acute myeloid leukemia. Egypt J Haematol. 2019, 44:157. 10.4103\/ejh.ejh_20_19","journal-title":"Egypt J Haematol"},{"key":"ref86","article-title":"Polymorphism of NAD (P) H: quinone oxidoreductase 1 and susceptibility to acute myeloid leukemia in Egyptian patients","volume":"5","author":"Ebid GT","year":"2009","unstructured":"Ebid GT, Gawdat RM, Mounir MM. Polymorphism of NAD (P) H: quinone oxidoreductase 1 and susceptibility to acute myeloid leukemia in Egyptian patients. J Egypt Soc Haematol Res. 2009, 5:21.","journal-title":"J Egypt Soc Haematol Res"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.2310\/JIM.0b013e3182281da3","article-title":"RAD51 and XRCC3 gene polymorphisms and the risk of developing acute myeloid leukemia","volume":"59","author":"Hamdy MS","year":"2011","unstructured":"Hamdy MS, El-Haddad AM, Bahaa El-Din NM, Makhlouf MM, Abdel-Hamid SM. RAD51 and XRCC3 gene polymorphisms and the risk of developing acute myeloid leukemia. J Investig Med. 2011, 59:1124-30. 10.2310\/JIM.0b013e3182281da3","journal-title":"J Investig Med"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2021.22.4.1035","article-title":"Association of SDF-1 gene polymorphism with increased risk of acute myeloid leukemia patients","volume":"22","author":"Aladle DA","year":"2021","unstructured":"Aladle DA, Ghannam MA, El-Ashwah S, Ghobrial FE, Mortada MI. Association of SDF-1 gene polymorphism with increased risk of acute myeloid leukemia patients. Asian Pac J Cancer Prev. 2021, 22:1035-43. 10.31557\/APJCP.2021.22.4.1035","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-019-01172-z","article-title":"TET2 single nucleotide polymorphism in myeloid neoplasms among Egyptian patients","volume":"36","author":"Dammag EA","year":"2020","unstructured":"Dammag EA, Hamed NA, Elhalawani NA, Kassem HS, Ayad MW. TET2 single nucleotide polymorphism in myeloid neoplasms among Egyptian patients. Indian J Hematol Blood Transfus. 2020, 36:91-6. 10.1007\/s12288-019-01172-z","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref90","article-title":"Vitamin D receptor gene polymorphism as a prognostic marker in acute myeloid leukemia patients","volume":"7","author":"Zidan AA","year":"2018","unstructured":"Zidan AA, Taleb FMA, Omran AAEM, Elnaggar OEAL. Vitamin D receptor gene polymorphism as a prognostic marker in acute myeloid leukemia patients. Int J Pharmaceut Res Allied Sci. 2018, 7:","journal-title":"Int J Pharmaceut Res Allied Sci"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1007\/s12308-017-0290-2","article-title":"Polymorphisms of xeroderma pigmentosum genes (XPC, XPD, and XPG) and susceptibility to acute leukemia among a sample of Egyptian patients","volume":"10","author":"ElMahgoub IR","year":"2017","unstructured":"ElMahgoub IR, Gouda HM, Samra MA, Shaheen IA, ElMaraashly AH. Polymorphisms of xeroderma pigmentosum genes (XPC, XPD, and XPG) and susceptibility to acute leukemia among a sample of Egyptian patients. J Hematopathol. 2017, 10:3-7. 10.1007\/s12308-017-0290-2","journal-title":"J Hematopathol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.4103\/ejh.ejh_22_19","article-title":"X-ray cross-complement 1 gene polymorphisms (Arg399Gln and Arg194Trp) in patients with acute myeloid leukemia","volume":"44","author":"Mortada M","year":"2019","unstructured":"Mortada M, El-Sebaie A, Aladle D, Elzaafarany M, Mahmoud LotfyAN. X-ray cross-complement 1 gene polymorphisms (Arg399Gln and Arg194Trp) in patients with acute myeloid leukemia. Egypt J Haematol. 2019, 44:175. 10.4103\/ejh.ejh_22_19","journal-title":"Egypt J Haematol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1007\/s00580-010-1120-4","article-title":"Detection of XRCC1 gene polymorphisms in Egyptian patients with acute myeloid leukemia","volume":"21","author":"El-Din MS","year":"2012","unstructured":"El-Din MS, Raslan H, Abdel-Hamid S, Makhlouf M. Detection of XRCC1 gene polymorphisms in Egyptian patients with acute myeloid leukemia. Comp Clin Pathol. 2012, 21:505-13. 10.1007\/s00580-010-1120-4","journal-title":"Comp Clin Pathol"},{"key":"ref94","article-title":"Risk and prognostic value of rad 51 and XRCC3 gene polymorphisms in Egyptian patients with acute myeloid leukemia","volume":"12","author":"Shafik NF","year":"2016","unstructured":"Shafik NF, Shafik RE, Shafik HE, Youakim MF. Risk and prognostic value of rad 51 and XRCC3 gene polymorphisms in Egyptian patients with acute myeloid leukemia. J Egypt Soc Haematol Res. 2016, 12:","journal-title":"J Egypt Soc Haematol Res"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2022.23.9.3229","article-title":"Interleukin-10-1082A>g (RS1800896) single nucleotide polymorphism is not a risk factor of chronic lymphocytic leukemia in Sudanese population","volume":"23","author":"Basabaeen AA","year":"2022","unstructured":"Basabaeen AA, Abdelgader EA, Ahmed EB, et al.. Interleukin-10-1082A>g (RS1800896) single nucleotide polymorphism is not a risk factor of chronic lymphocytic leukemia in Sudanese population. Asian Pac J Cancer Prev. 2022, 23:3229-35. 10.31557\/APJCP.2022.23.9.3229","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.4103\/mmj.mmj_132_19","article-title":"Vascular endothelial growth factor gene polymorphism in Egyptian patients with B-cell chronic lymphocytic leukemia","volume":"33","author":"Elkhouly E","year":"2020","unstructured":"Elkhouly E, Ahmedy I, Soliman M, El-Din R, Zanaty S. Vascular endothelial growth factor gene polymorphism in Egyptian patients with B-cell chronic lymphocytic leukemia. Menoufia Med J. 2020, 33:942-8. 10.4103\/mmj.mmj_132_19","journal-title":"Menoufia Med J"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2022.23.10.3449","article-title":"TNF-\u03b1-308A allele carrier induced to development of chronic lymphocytic leukemia in Sudanese population at earlier age","volume":"23","author":"Basabaeen AA","year":"2022","unstructured":"Basabaeen AA, Abdelgader EA, Ahmed Babekir E, et al.. TNF-\u03b1-308A allele carrier induced to development of chronic lymphocytic leukemia in Sudanese population at earlier age. Asian Pac J Cancer Prev. 2022, 23:3449-55. 10.31557\/APJCP.2022.23.10.3449","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1272876","article-title":"TP53 Gene 72 Arg\/Pro (rs1042522) single nucleotide polymorphism increases the risk and the severity of chronic lymphocytic leukemia","volume":"13","author":"Ounalli A","year":"2023","unstructured":"Ounalli A, Moumni I, Mechaal A, et al.. TP53 Gene 72 Arg\/Pro (rs1042522) single nucleotide polymorphism increases the risk and the severity of chronic lymphocytic leukemia. Front Oncol. 2023, 13:1272876. 10.3389\/fonc.2023.1272876","journal-title":"Front Oncol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.4999\/uhod.193355","article-title":"Angiotensin converting enzyme insertion\/deletion gene polymorphisms in Sudanese patients with chronic lymphocytic leukaemia","volume":"29","author":"Ibrahim IK","year":"2019","unstructured":"Ibrahim IK. Angiotensin converting enzyme insertion\/deletion gene polymorphisms in Sudanese patients with chronic lymphocytic leukaemia. UHOD. 2019, 29:46-50. 10.4999\/uhod.193355","journal-title":"UHOD"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1007\/s00580-012-1447-0","article-title":"CD38 Gene polymorphisms and susceptibility to B cell chronic lymphocytic leukemia","volume":"22","author":"Eyada TK","year":"2013","unstructured":"Eyada TK, Hussein SK, Younan SA, Abd El Ghany WM, Malek RA. CD38 Gene polymorphisms and susceptibility to B cell chronic lymphocytic leukemia. Comp Clin Pathol. 2013, 22:573-9. 10.1007\/s00580-012-1447-0","journal-title":"Comp Clin Pathol"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1007\/s00580-020-03139-3","article-title":"Impact of IL-10 gene promoter -1082 (G\/A) polymorphism in B cell chronic lymphocytic leukemia","volume":"29","author":"Aref S","year":"2020","unstructured":"Aref S, Mohamed A, El Shehawy H, Azmy E. Impact of IL-10 gene promoter -1082 (G\/A) polymorphism in B cell chronic lymphocytic leukemia. Comp Clin Pathol. 2020, 29:777-85. 10.1007\/s00580-020-03139-3","journal-title":"Comp Clin Pathol"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.15406\/htij.2019.07.00198","article-title":"MicroRNA-196a2 single nucleotide polymorphism rs11614913 in Egyptian patients with chronic lymphocytic leukemia","volume":"7","author":"Deghady A","year":"2019","unstructured":"Deghady A, Elwafa RA, Lsorady, MA, Elbana D. MicroRNA-196a2 single nucleotide polymorphism rs11614913 in Egyptian patients with chronic lymphocytic leukemia. HTIJ. 2019, 7:17-20. 10.15406\/htij.2019.07.00198","journal-title":"HTIJ"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2019.20.5.1579","article-title":"TP53 gene 72 Arg\/Pro (rs1042522) single nucleotide polymorphism contribute to increase the risk of B-chronic lymphocytic leukemia in the Sudanese population","volume":"20","author":"Mohammed Basabaeen AA","year":"2019","unstructured":"Mohammed Basabaeen AA, Abdelgader EA, Babekir EA, et al.. TP53 gene 72 Arg\/Pro (rs1042522) single nucleotide polymorphism contribute to increase the risk of B-chronic lymphocytic leukemia in the Sudanese population. Asian Pac J Cancer Prev. 2019, 20:1579-85. 10.31557\/APJCP.2019.20.5.1579","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref104","article-title":"Vitamin D receptor gene (FokI) polymorphism in Sudanese patients with chronic lymphocytic leukaemia","volume":"3","author":"Rajab SA","year":"2015","unstructured":"Rajab SA, Ibrahim IK, Abdelgader EA, Rahman EMA, Abdalla MH. Vitamin D receptor gene (FokI) polymorphism in Sudanese patients with chronic lymphocytic leukaemia. Am J Res Commun. 2015, 3:71-8.","journal-title":"Am J Res Commun"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-013-0794-2","article-title":"Methylene tetrahydrofolate reductase (MTHFR) gene polymorphisms in chronic myeloid leukemia: an Egyptian study","volume":"31","author":"Khorshied MM","year":"2014","unstructured":"Khorshied MM, Shaheen IA, Abu Khalil RE, Sheir RE. Methylene tetrahydrofolate reductase (MTHFR) gene polymorphisms in chronic myeloid leukemia: an Egyptian study. Med Oncol. 2014, 31:794. 10.1007\/s12032-013-0794-2","journal-title":"Med Oncol"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.mgene.2021.100865","article-title":"Effects of GSTP1 Ile105Val polymorphism on both susceptibility and treatment response of chronic myeloid leukemia","volume":"28","author":"Kaltoum ABO","year":"2021","unstructured":"Kaltoum ABO, Hind D, Meryem Q, Yaya K, Sellama N, Asma Q. Effects of GSTP1 Ile105Val polymorphism on both susceptibility and treatment response of chronic myeloid leukemia. Meta Gene. 2021, 28:100865. 10.1016\/j.mgene.2021.100865","journal-title":"Meta Gene"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2020.004","article-title":"The prognostic significance of TET2 single nucleotide polymorphism in Egyptian chronic myeloid leukemia","volume":"12","author":"Hamed NA","year":"2020","unstructured":"Hamed NA, Elhalawani NA, Kassem HS, Ayad MW, Dammag EA. The prognostic significance of TET2 single nucleotide polymorphism in Egyptian chronic myeloid leukemia. Mediterr J Hematol Infect Dis. 2020, 12:e2020004. 10.4084\/MJHID.2020.004","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.2174\/1570163817666200518081356","article-title":"CYP1A1 and CYP2D6 polymorphisms and susceptibility to chronic myelocytic leukaemia","volume":"20","author":"Idris HM","year":"2020","unstructured":"Idris HM, Khalil HB, Mills J, Elderdery AY. CYP1A1 and CYP2D6 polymorphisms and susceptibility to chronic myelocytic leukaemia. Curr Cancer Drug Targets. 2020, 20:675-80. 10.2174\/1570163817666200518081356","journal-title":"Curr Cancer Drug Targets"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0889-4","article-title":"Influence of CYP1A1, GST polymorphisms and susceptibility risk of chronic myeloid leukemia in Syrian population","volume":"31","author":"Al-Achkar W","year":"2014","unstructured":"Al-Achkar W, Azeiz G, Moassass F, Wafa A. Influence of CYP1A1, GST polymorphisms and susceptibility risk of chronic myeloid leukemia in Syrian population. Med Oncol. 2014, 31:889. 10.1007\/s12032-014-0889-4","journal-title":"Med Oncol"},{"key":"ref110","article-title":"Study of the association of CYP2d6*4 polymorphism with the risk of chronic myeloid leukemia","volume":"19","author":"Sahar H","year":"2010","unstructured":"Sahar H, Asmaa AA, Reham A, Noha EH. Study of the association of CYP2d6*4 polymorphism with the risk of chronic myeloid leukemia. Egypt J Exp Biol (Zool). 2010, 19:71-8.","journal-title":"Egypt J Exp Biol (Zool)"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-96131\/v1","article-title":"CYP3A5*3 gene polymorphism among Sudanese patients with chronic myeloid leukemia  in","author":"Abdallah EI","year":"2020","unstructured":"Abdallah EI, M.Alamin NI, Elradi WEO, Elzaki SEG, Shrif NMA. CYP3A5*3 gene polymorphism among Sudanese patients with chronic myeloid leukemia  in. Review. 2020, 10.21203\/rs.3.rs-96131\/v1","journal-title":"Review"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S342625","article-title":"Combined GSTT1 null, GSTM1 null and XPD Lys\/Lys genetic polymorphisms and their association with increased risk of chronic myeloid leukemia","volume":"14","author":"Abdalhabib EK","year":"2021","unstructured":"Abdalhabib EK, Jackson DE, Alzahrani B, et al.. Combined GSTT1 null, GSTM1 null and XPD Lys\/Lys genetic polymorphisms and their association with increased risk of chronic myeloid leukemia. Pharmgenomics Pers Med. 2021, 14:1661-7. 10.2147\/PGPM.S342625","journal-title":"Pharmgenomics Pers Med"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2020.21.2.499","article-title":"Genetic polymorphism of GSTP1, GSTM1 and GSTT1 genes and susceptibility to chronic myeloid leukaemia","volume":"21","author":"Idris HM","year":"2020","unstructured":"Idris HM, Elderdery AY, Khalil HB, Mills J. Genetic polymorphism of GSTP1, GSTM1 and GSTT1 genes and susceptibility to chronic myeloid leukaemia. Asian Pac J Cancer Prev. 2020, 21:499-503. 10.31557\/APJCP.2020.21.2.499","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2019.4176","article-title":"Age- and gender-independent association of glutathione S-transferase null polymorphisms with chronic myeloid leukemia","volume":"19","author":"Muddathir AR","year":"2019","unstructured":"Muddathir AR, Abdallah EI, Khabour OF, Abdelgader RE, Elgari MM. Age- and gender-independent association of glutathione S-transferase null polymorphisms with chronic myeloid leukemia. Bosn J Basic Med Sci. 2019, 19:350-4. 10.17305\/bjbms.2019.4176","journal-title":"Bosn J Basic Med Sci"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1016\/j.mgene.2017.02.006","article-title":"Effect of Glutathione S-transferase mu 1 ( GSTM1 ) gene polymorphism on chronic myeloid leukemia risk and Imatinib treatment response","volume":"12","author":"Al-Achkar W","year":"2017","unstructured":"Al-Achkar W, Moassass F, Aroutiounian R, Harutyunyan T, Liehr T, Wafa A. Effect of Glutathione S-transferase mu 1 ( GSTM1 ) gene polymorphism on chronic myeloid leukemia risk and Imatinib treatment response. Meta Gene. 2017, 12:113-7. 10.1016\/j.mgene.2017.02.006","journal-title":"Meta Gene"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.21271\/ZJPAS.32.6.6","article-title":"Glutathione S-transferase Mu 1 and glutathione S-transferase theta 1 genes polymorphism and susceptibility to chronic myeloid leukemia in Erbil-Iraq Kurdistan Region","volume":"32","author":"Aali MH","year":"2020","unstructured":"Aali MH, Qader GM, Al-Attar MS, Rajab MF, Shehka MS. Glutathione S-transferase Mu 1 and glutathione S-transferase theta 1 genes polymorphism and susceptibility to chronic myeloid leukemia in Erbil-Iraq Kurdistan Region. ZJPAS. 2020, 32:10.21271\/ZJPAS.32.6.6","journal-title":"ZJPAS"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-0966-y","article-title":"Association of glutathione S-transferase (GSTM1 and GSTT1) genes with chronic myeloid leukemia","volume":"4","author":"Kassogue Y","year":"2015","unstructured":"Kassogue Y, Dehbi H, Quachouh M, Quessar A, Benchekroun S, Nadifi S. Association of glutathione S-transferase (GSTM1 and GSTT1) genes with chronic myeloid leukemia. Springerplus. 2015, 4:210. 10.1186\/s40064-015-0966-y","journal-title":"Springerplus"},{"key":"ref118","article-title":"Frequency of GSTP1 (Ile105Val) gene polymorphism in Iraqi CML patients and its association with susceptibility to CML","volume":"11","author":"Alaqidi AAH","year":"2019","unstructured":"Alaqidi AAH, Alwash MM. Frequency of GSTP1 (Ile105Val) gene polymorphism in Iraqi CML patients and its association with susceptibility to CML. J Pharm Sci. 2019, 11:819-23.","journal-title":"J Pharm Sci"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.4103\/1110-1067.186408","article-title":"Glutathione-S-transferase P1 as a risk factor for Egyptian patients with chronic myeloid leukemia","volume":"41","author":"Hamed NahlaAM","year":"2016","unstructured":"Hamed NahlaAM, Ghallab O, El-Neily D. Glutathione-S-transferase P1 as a risk factor for Egyptian patients with chronic myeloid leukemia. Egypt J Haematol. 2016, 41:65. 10.4103\/1110-1067.186408","journal-title":"Egypt J Haematol"},{"key":"ref120","article-title":"Association of vitamin D receptor (VDR) start codon Fok-I polymorphism with chronic myeloid leukemia","volume":"4","author":"Algadal SFS","year":"2015","unstructured":"Algadal SFS, Ali EW, Elamin HA, Ahmed MAM, Babiker EA. Association of vitamin D receptor (VDR) start codon Fok-I polymorphism with chronic myeloid leukemia. IJAPBC. 2015, 4:228-32.","journal-title":"IJAPBC"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.36103\/ijas.v53i3.1558","article-title":"Genetic polymorhism of caspase 8 and 9 in Iraq","volume":"53","author":"Abdullah D","year":"2022","unstructured":"Abdullah D, Aloubaidy RM. Genetic polymorhism of caspase 8 and 9 in Iraq. Iraqi J Agric Sci. 2022, 53:505-14. 10.36103\/ijas.v53i3.1558","journal-title":"Iraqi J Agric Sci"},{"key":"ref122","article-title":"Detection of genetic polymorphisms of methylene tetrahydrofolate reductase among Sudanese patients with chronic myeloid leukemia","volume":"13","author":"Tebien EM","year":"2019","unstructured":"Tebien EM, Elderdery AY, Mills J, Khalil HB. Detection of genetic polymorphisms of methylene tetrahydrofolate reductase among Sudanese patients with chronic myeloid leukemia. P J M H S. 2019, 13:1325-9.","journal-title":"P J M H S"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v9i6.3693","article-title":"Detection of methylene tetrahydrofolate reductase gene polymorphism (C677T) in Sudanese patients with chronic myeloid leukemia","volume":"9","author":"Osman NA","year":"2019","unstructured":"Osman NA, Gassoum A, Ahmed SA, Babiker NE. Detection of methylene tetrahydrofolate reductase gene polymorphism (C677T) in Sudanese patients with chronic myeloid leukemia. J Drug Delivery Ther. 2019, 9:162-8. 10.22270\/jddt.v9i6.3693","journal-title":"J Drug Delivery Ther"},{"key":"ref124","article-title":"MTHFR A1298C and C677T gene polymorphisms and susceptibility to chronic myeloid leukemia in Egypt","volume":"7","author":"Aly RM","year":"2014","unstructured":"Aly RM, Taalab MM, Ghazy HF. MTHFR A1298C and C677T gene polymorphisms and susceptibility to chronic myeloid leukemia in Egypt. Int J Clin Exp Pathol. 2014, 7:2571-8.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref125","article-title":"Methylenetetrahydrofolate reductase (MTHFR) genotype association with the risk of chronic myelogenous leukemia","volume":"43","author":"Ismail S","year":"2009","unstructured":"Ismail S, Ababneh N, Awidi A. Methylenetetrahydrofolate reductase (MTHFR) genotype association with the risk of chronic myelogenous leukemia. Jor Med J. 2009, 43:","journal-title":"Jor Med J"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2012.05.008","article-title":"KIT mutation detection in Tunisian patients with newly diagnosed myelogenous leukemia: prevalence and prognostic significance","volume":"205","author":"Ouerhani S","year":"2012","unstructured":"Ouerhani S, Gharbi H, Menif S, Safra I, Douzi K, Abbes S. KIT mutation detection in Tunisian patients with newly diagnosed myelogenous leukemia: prevalence and prognostic significance. Cancer Genet. 2012, 205:436-41. 10.1016\/j.cancergen.2012.05.008","journal-title":"Cancer Genet"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2020.21.12.3711","article-title":"Evaluation of genetic polymorphisms of N-acetyltransferase 2 and relation with chronic myeloid leukemia","volume":"21","author":"Tebien EM","year":"2020","unstructured":"Tebien EM, Khalil HB, Mills J, Elderdery AY. Evaluation of genetic polymorphisms of N-acetyltransferase 2 and relation with chronic myeloid leukemia. Asian Pac J Cancer Prev. 2020, 21:3711-7. 10.31557\/APJCP.2020.21.12.3711","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2400-4","article-title":"Single nucleotide polymorphisms of multidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia","volume":"35","author":"Yaya K","year":"2014","unstructured":"Yaya K, Hind D, Meryem Q, Asma Q, Said B, Sellama N. Single nucleotide polymorphisms of multidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia. Tumour Biol. 2014, 35:10969-75. 10.1007\/s13277-014-2400-4","journal-title":"Tumour Biol"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034819","article-title":"Epidemiology and etiology of leukemia and lymphoma","volume":"10","author":"Bispo JA","year":"2020","unstructured":"Bispo JA, Pinheiro PS, Kobetz EK. Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harb Perspect Med. 2020, 10:10.1101\/cshperspect.a034819","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00598","article-title":"The role of ARID5B in acute lymphoblastic leukemia and beyond","volume":"11","author":"Wang P","year":"2020","unstructured":"Wang P, Deng Y, Yan X, et al.. The role of ARID5B in acute lymphoblastic leukemia and beyond. Front Genet. 2020, 11:598. 10.3389\/fgene.2020.00598","journal-title":"Front Genet"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.16.3.792","article-title":"Characterization of the dead ringer gene identifies a novel, highly conserved family of sequence-specific DNA-binding proteins","volume":"16","author":"Gregory SL","year":"1996","unstructured":"Gregory SL, Kortschak RD, Kalionis B, Saint R. Characterization of the dead ringer gene identifies a novel, highly conserved family of sequence-specific DNA-binding proteins. Mol Cell Biol. 1996, 16:792-9. 10.1128\/MCB.16.3.792","journal-title":"Mol Cell Biol"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.2174\/092986711797379267","article-title":"A structure-function perspective of Jak2 mutations and implications for alternate drug design strategies: the road not taken","volume":"18","author":"Gnanasambandan K","year":"2011","unstructured":"Gnanasambandan K, Sayeski PP. A structure-function perspective of Jak2 mutations and implications for alternate drug design strategies: the road not taken. Curr Med Chem. 2011, 18:4659-73. 10.2174\/092986711797379267","journal-title":"Curr Med Chem"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.669363","article-title":"JAK-STAT in early hematopoiesis and leukemia","volume":"9","author":"Fasouli ES","year":"2021","unstructured":"Fasouli ES, Katsantoni E. JAK-STAT in early hematopoiesis and leukemia. Front Cell Dev Biol. 2021, 9:669363. 10.3389\/fcell.2021.669363","journal-title":"Front Cell Dev Biol"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050273","article-title":"Functions of the MDM2 oncoprotein","volume":"55","author":"Freedman DA","year":"1999","unstructured":"Freedman DA, Wu L, Levine AJ. Functions of the MDM2 oncoprotein. Cell Mol Life Sci. 1999, 55:96-107. 10.1007\/s000180050273","journal-title":"Cell Mol Life Sci"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006043","article-title":"The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study","volume":"6","author":"Mascarenhas J","year":"2022","unstructured":"Mascarenhas J, Passamonti F, Burbury K, et al.. The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study. Blood Adv. 2022, 6:1162-74. 10.1182\/bloodadvances.2021006043","journal-title":"Blood Adv"},{"key":"ref136","article-title":"Chapter 8 - Role of Human Xeroderma Pigmentosum Group D (XPD) Helicase in Various Cellular Pathways","author":"Vashisht AA","year":"2019","unstructured":"Vashisht AA, Wohlschlegel JA. Chapter 8 - Role of Human Xeroderma Pigmentosum Group D (XPD) Helicase in Various Cellular Pathways. Helicases from All Domains of Life. Tuteja R (ed): Academic Press, 2019. 125-39."},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1512655112","article-title":"Independent regulation of vertebral number and vertebral identity by microRNA-196 paralogs","volume":"112","author":"Wong SF","year":"2015","unstructured":"Wong SF, Agarwal V, Mansfield JH, et al.. Independent regulation of vertebral number and vertebral identity by microRNA-196 paralogs. Proc Natl Acad Sci U S A. 2015, 112:E4884-93. 10.1073\/pnas.1512655112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S92259","article-title":"Genetic polymorphisms of CYP1A1 and risk of leukemia: a meta-analysis","volume":"8","author":"Lu J","year":"2015","unstructured":"Lu J, Zhao Q, Zhai YJ, et al.. Genetic polymorphisms of CYP1A1 and risk of leukemia: a meta-analysis. Onco Targets Ther. 2015, 8:2883-902. 10.2147\/OTT.S92259","journal-title":"Onco Targets Ther"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1159\/000083333","article-title":"Genetic diversity among the Arabs","volume":"8","author":"Teebi AS","year":"2005","unstructured":"Teebi AS, Teebi SA. Genetic diversity among the Arabs. Commun Genet. 2005, 8:21-6. 10.1159\/000083333","journal-title":"Commun Genet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/261623-genetic-insights-into-leukemia-susceptibility-in-the-arab-population-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T23:01:14Z","timestamp":1724281274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/261623-genetic-insights-into-leukemia-susceptibility-in-the-arab-population-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":139,"URL":"https:\/\/doi.org\/10.7759\/cureus.67421","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,21]]}}}